Bristol-Meyers Squibb : Cramer likes the dividend but said the growth has been lacking. He recommended the company sell itself to Merck or Pfizer . Still he’s bullish on BMY.
Gafisa : Cramer’s bullish on Gafisa. He said he was time to go back to another Brazilian play, Vale .
Questions for Cramer? email@example.com
Questions, comments, suggestions for the Mad Money website? firstname.lastname@example.org